Table 2.
Adherence to anti-Covid-19 vaccinations, adverse events and Sars-CoV-2 infection during study period
| IBD populationN = 470 | |
|---|---|
| Anti Covid-19 vaccination; n (%) | |
| Administered | 400 (85) |
| Procrastinators | 44 (9) |
| Refusal | 27 (6) |
| Type of vaccine; n (%) | |
| BNT162b2 | 362 (91) |
| ChAdOx1 | 9 (2) |
| mRNA-1273 | 29 (7) |
| Adverse events; no. of patients (%) | 125 (31) |
| Pain at the injection site | 84 (21) |
| Fever | 55 (14) |
| Muscle pain | 43 (11) |
| Asthenia | 42 (11) |
| Headache | 23 (6) |
| Diarrhoea and abdominal discomfort | 4 (1) |
| Other | 7 (2) |
| Hospitalization | 2 (0.5) |
| COVID Infection during study period; n (%) | 53 (10) |
Data are expressed as numbers (percentages). Percentages for adverse events do not sum up to 100% as more than one AE could have been present in the same patient.